YF-VAX 1 dose vials
Ended Awarded Last action
- Contract number
- SPE2DR26FJXF7
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,259
Award facts
- Contract value 100% obligated
- $1,259.08 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $1,259.08 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for YF-VAX (yellow fever vaccine) in single-dose vial format. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of February 17, 2026, and no set-aside designation was used in the award. DMS Pharmaceutical Group will fulfill this requirement from its Park Ridge, Illinois location, leveraging its established position as a critical supplier within the federal pharmaceutical supply chain.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, awarded in November 2025 with a $499.999 billion ceiling value through December 31, 2036. The PPV-G GEN V program represents a $30.3 billion government-wide acquisition strategy designed to establish regional prime vendor contractors supplying comprehensive pharmaceutical products and medical consumables to Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group's selection demonstrates its competitive capability to provide diverse pharmaceutical requirements, including vaccines, specialty pharmaceuticals, biologics, and routine medications essential to military medical operations globally.
Quick answers
Who was awarded contract SPE2DR26FJXF7?
SPE2DR26FJXF7 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 26, 2026.
How much is contract SPE2DR26FJXF7 worth?
The government has obligated $1,259 on SPE2DR26FJXF7.
Is contract SPE2DR26FJXF7 an order under another contract?
Yes. SPE2DR26FJXF7 is a delivery order under SPE2DR25D9307, an indefinite delivery contract.
Was contract SPE2DR26FJXF7 competed?
The extent of competition for SPE2DR26FJXF7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award